SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?


To: Knighty Tin who wrote (77798)3/13/2000 10:53:00 PM
From: Skeeter Bug  Read Replies (1) | Respond to of 132070
 
>>Tip, Actually, people do NOT like trading earnings.<<

old economy, bruddah! get wit da pictah, dood. trading ernin's is da besss kinda ernins ther is. garntead 50-100% a year, bruddah. too bad intel has an actual binness to support.

steve, get away from thee! ;-)



To: Knighty Tin who wrote (77798)3/13/2000 10:57:00 PM
From: Nadine Carroll  Read Replies (1) | Respond to of 132070
 
Michael,

Have you ever given the hairy eyeball to QLT PhotoTherapeutics Inc (QLTI)? They make the drug, Visudyne, that is used in PhotoDynamic Treatment (PDT). In particular, its use in treating the wet form of macular generation is awaiting FDA approval. The wet form of macular generation affects half a million older people per year, causes almost total loss of central vision, and there is currently no treatment available for most of the cases.

Here is the conference call from last November. Of particular note is the fact that Medicare has indicated (prior to FDA approval!) that they would pay for the treatment.

Message 12049009

Since then, QLTI has gone up with the biotechs, then suffered somewhat when the FDA gave it only an "approvable" letter by the February deadline instead of full approval. It just means, as far as I can see, that they ran out of time to finish their review.

When Photodynamic Treatment for macular generation is approved, there is going to be a stampede. Hundreds of thousands of people (my father among them) are going blind inch by inch with no available treatment.

I'd love to see your opinion on this one.

BTW, thanks for VASO! I hope QLTI can pay back the tip.



To: Knighty Tin who wrote (77798)3/13/2000 11:44:00 PM
From: Les H  Read Replies (4) | Respond to of 132070
 
BLS to extend hedonic pricing to VCRs and DVD players

nypostonline.com

"We are on a permanent plateau of hedonicly priced prosperity"

I'm surprised someone hasn't wised up enough to sue them, especially with hundreds of billions of dollars at stake.



To: Knighty Tin who wrote (77798)3/14/2000 1:39:00 PM
From: Martin A. Helfand  Read Replies (1) | Respond to of 132070
 
MB,
A question regarding exit strategies on winners with a full position; do you recommend thirds or wholes? Also, your thoughts on the pros vs cons of taking profits but leaving the initial investment intact.

TIA, Marty